152 related articles for article (PubMed ID: 15072445)
1. Protein expression of Fas, Fas ligand, Bcl-2 and TGFbeta2 and correlation with survival in initial and recurrent human gliomas.
Strege RJ; Godt C; Stark AM; Hugo HH; Mehdorn HM
J Neurooncol; 2004; 67(1-2):29-39. PubMed ID: 15072445
[TBL] [Abstract][Full Text] [Related]
2. Human astrocytomas co-expressing Fas and Fas ligand also produce TGFbeta2 and Bcl-2.
Frankel B; Longo SL; Ryken TC
J Neurooncol; 1999; 44(3):205-12. PubMed ID: 10720200
[TBL] [Abstract][Full Text] [Related]
3. Co-expression of Fas and Fas ligand in human non-astrocytic glial tumors.
Frankel B; Longo SL; Ryken TC
Acta Neuropathol; 1999 Oct; 98(4):363-6. PubMed ID: 10502041
[TBL] [Abstract][Full Text] [Related]
4. Expression of growth factors in brain tumors: correlation with tumor grade, recurrence and survival.
Maiuri F; Del Basso De Caro M; Siciliano A; Peca C; Vergara P; Mariniello G; Pettinato G
Clin Neuropathol; 2010; 29(2):109-14. PubMed ID: 20175962
[TBL] [Abstract][Full Text] [Related]
5. Fas ligand expression in glioblastoma cell lines and primary astrocytic brain tumors.
Gratas C; Tohma Y; Van Meir EG; Klein M; Tenan M; Ishii N; Tachibana O; Kleihues P; Ohgaki H
Brain Pathol; 1997 Jul; 7(3):863-9. PubMed ID: 9217971
[TBL] [Abstract][Full Text] [Related]
6. Glioma apoptosis induced by macrophages involves both death receptor-dependent and independent pathways.
Chen GG; Chak EC; Chun YS; Lam IK; Sin FL; Leung BC; Ng HK; Poon WS
J Lab Clin Med; 2003 Mar; 141(3):190-9. PubMed ID: 12624600
[TBL] [Abstract][Full Text] [Related]
7. Possible involvement of Fas system in the induction of apoptosis in human astrocytic brain tumors.
Fujita H; Koji T; Kitagawa N; Tsutsumi K; Abe K; Kaminogo M; Shibata S
Cell Mol Neurobiol; 2002 Aug; 22(4):393-406. PubMed ID: 12507389
[TBL] [Abstract][Full Text] [Related]
8. Expression of Fas ligand and bcl-2 in cervical carcinoma and their prognostic significance.
Munakata S; Watanabe O; Ohashi K; Morino H
Am J Clin Pathol; 2005 Jun; 123(6):879-85. PubMed ID: 15899779
[TBL] [Abstract][Full Text] [Related]
9. Fas (Apo-1, CD95) receptor expression in childhood astrocytomas. Is it a marker of the major apoptotic pathway or a signaling receptor for immune escape of neoplastic cells?
Bodey B; Bodey B; Siegel SE; Kaiser HE
In Vivo; 1999; 13(4):357-73. PubMed ID: 10586378
[TBL] [Abstract][Full Text] [Related]
10. Expression of TGF-beta isoforms, TGF-beta receptors, and SMAD molecules at different stages of human glioma.
Kjellman C; Olofsson SP; Hansson O; Von Schantz T; Lindvall M; Nilsson I; Salford LG; Sjögren HO; Widegren B
Int J Cancer; 2000 May; 89(3):251-8. PubMed ID: 10861501
[TBL] [Abstract][Full Text] [Related]
11. Fas (APO-1/CD95) ligand and Fas expression in renal cell carcinomas: correlation with the prognostic factors.
Kim YS; Kim KH; Choi JA; Lee JH; Kim HK; Won NH; Kim I
Arch Pathol Lab Med; 2000 May; 124(5):687-93. PubMed ID: 10782148
[TBL] [Abstract][Full Text] [Related]
12. [Relationship of bcl-2 gene expression with cell proliferation and apoptosis in human gliomas].
Yu S; Pu P; Jiang D; An T; Guan X; Yang L
Zhonghua Bing Li Xue Za Zhi; 2000 Feb; 29(1):12-5. PubMed ID: 11866884
[TBL] [Abstract][Full Text] [Related]
13. Fas and Fas ligand expression in the salivary glands of patients with primary Sjögren's syndrome.
Kong L; Ogawa N; Nakabayashi T; Liu GT; D'Souza E; McGuff HS; Guerrero D; Talal N; Dang H
Arthritis Rheum; 1997 Jan; 40(1):87-97. PubMed ID: 9008604
[TBL] [Abstract][Full Text] [Related]
14. Co-expression of Fas and Fas ligand in malignant glial tumors and cell lines.
Husain N; Chiocca EA; Rainov N; Louis DN; Zervas NT
Acta Neuropathol; 1998 Mar; 95(3):287-90. PubMed ID: 9542594
[TBL] [Abstract][Full Text] [Related]
15. TP53 gene mutations, nuclear p53 accumulation, expression of Waf/p21, Bcl-2, and CD95 (APO-1/Fas) proteins are not prognostic factors in de novo glioblastoma multiforme.
Kraus JA; Wenghoefer M; Glesmann N; Mohr S; Beck M; Schmidt MC; Schröder R; Berweiler U; Roggendorf W; Diete S; Dietzmann K; Heuser K; Müller B; Fimmers R; von Deimling A; Schlegel U
J Neurooncol; 2001 May; 52(3):263-72. PubMed ID: 11519857
[TBL] [Abstract][Full Text] [Related]
16. Relationship of Fas, FasL, p53 and bcl-2 expression in human non-small cell lung carcinomas.
Li Y; Xu KP; Jiang D; Zhao J; Ge JF; Zheng SY
Int J Clin Exp Pathol; 2015; 8(11):13978-86. PubMed ID: 26823709
[TBL] [Abstract][Full Text] [Related]
17. The expression of apoptosis-related proteins and the apoptotic rate in glial tumors of the brain.
Ehrmann J; Riháková P; Hlobilková A; Kala M; Kolár Z
Neoplasma; 2000; 47(3):151-5. PubMed ID: 11043837
[TBL] [Abstract][Full Text] [Related]
18. Expression of apoptosis proteins in chronic myelogenous leukemia: associations and significance.
Ravandi F; Kantarjian HM; Talpaz M; O'Brien S; Faderl S; Giles FJ; Thomas D; Cortes J; Andreeff M; Estrov Z; Rios MB; Albitar M
Cancer; 2001 Jun; 91(11):1964-72. PubMed ID: 11391574
[TBL] [Abstract][Full Text] [Related]
19. Loss of the AP-2alpha transcription factor is associated with the grade of human gliomas.
Heimberger AB; McGary EC; Suki D; Ruiz M; Wang H; Fuller GN; Bar-Eli M
Clin Cancer Res; 2005 Jan; 11(1):267-72. PubMed ID: 15671555
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the expanded T cell population in infectious mononucleosis: apoptosis, expression of apoptosis-related genes, and Epstein-Barr virus (EBV) status.
Verbeke CS; Wenthe U; Bergler WF; Zentgraf H
Clin Exp Immunol; 2000 May; 120(2):294-300. PubMed ID: 10792379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
